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These are the first reported human cases of
West Nile fever in Central Europe (5); an
extensive outbreak occurred in Romania in 1996,
with approximately 500 patients hospitalized
and a 4% to 8% fatality rate (6,7). West Nile virus
should be viewed as a potential agent of local
sporadic cases, clusters, or outbreaks, even in
temperate Europe. Environmental factors (in-
cluding human activities) that enhance vector
population densities (heavy rains followed by
floods, irrigation, higher than usual tempera-
tures due to global warming) might produce an
increased incidence of West Nile fever and other
new or reemerging mosquito-borne diseases.
Surveillance for West Nile fever should monitor
population density and infection rate of principal
vectors, antibodies in vertebrates and exposed
human groups, and routine diagnosis of human
infections.
Zdenek Hubálek, Jirí Halouzka, and
Zina Juricová
Institute of Vertebrate Biology, Academy of Sciences,
Brno, Czech Republic
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Ofloxacin-Resistant Vibrio cholerae O139
in Hong Kong
To the Editor: Unexpected outbreaks of cholera
occurred in many areas of the world in 1997-98,
partly because of weather changes associated
with the El Niño phenomenon (1). Outbreaks
caused by antibiotic-resistant Vibrio cholerae O1
and O139 have been documented in the Indian
subcontinent (2-4), Africa (5), and Ukraine (6).
In Hong Kong, nonduplicate bacterial
strains of V. cholerae O1 and O139 isolated from
patients and environmental sources and re-
ceived in the Public Health Laboratory between
January 1, 1993, and June 30, 1998, were
identified by conventional biochemical tests (7,8)
and API 20E (bioMerieux, France); serotyped by
slide agglutination with polyvalent O1 and
mono-specific Inaba and Ogawa antisera
(Murex, Dartford, United Kingdom); and
checked with O139 antiserum (Denka Seiken,
Tokyo, Japan). Biotyped and antibiotic suscepti-
bilities were determined by the Kirby-Bauer
disk-diffusion assay (8-10). Antibiotics tested
included chloramphenicol and tetracycline (from
1993 to 1996) and ofloxacin (added in routine
testing from 1997). V. cholerae isolates available
for further study were tested with the standard
broth microdilution method (11) to measure
minimum inhibitory concentrations (MICs) of
susceptibilities to chloramphenicol, tetracycline,
and ofloxacin.
No antibiotic resistance was seen in
V. cholerae isolates in testing conducted from
1969 to 1995. The first V. cholerae isolate with
reduced susceptibility to chloramphenicol but
sensitive to tetracycline was encountered in
Hong Kong in 1996. This O1 El Tor Ogawa strain
was imported from Nepal. Since then, more O1
strains were isolated that exhibited reduced
antibiotic susceptibilities to chloramphenicol
and tetracycline but not to ofloxacin (12). In May
1998, seven V. cholerae O139 strains were
isolated that displayed patterns of antibiotic
susceptibilities strikingly different from those of
O1 isolates; the former were all sensitive to
tetracycline but showed reduced susceptibilities
to chloramphenicol and ofloxacin. All V. cholerae
O1 strains tested have been susceptible to
ofloxacin; O1 isolates falling into intermediate
categories for chloramphenicol and tetracycline
susceptibilities (31% and 27.6%, respectively)
were common.
The first isolate of V. cholerae O139 in Hong
Kong came from the imported case of a patient
who had traveled to other provinces of China
(13,14). Isolation of O139 continued sporadically
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1st quarter of 1998. In May 1998, a cluster of
seven imported cases of V. cholerae O139 were
reported with strains isolated from seven
persons who became ill with severe diarrhea
after visiting Zhuhai in Guangdong Province,
China. Of 13 V. cholerae O139 isolates tested, 7
showed intermediate resistance to chloram-
phenicol and high-level resistance to ofloxacin
(MIC 16 mg/ml) but no resistance to tetracycline
(MIC 50s and MIC 90s were 0.25 mg/ml). This is
the first evidence of a quinolone-resistant strain
of V. cholerae O139 in Hong Kong. Of the O1
isolates, none were resistant to chloramphenicol
and ofloxacin, but six were resistant to
tetracycline (MIC 50s and MIC 90s were 0.25 mg/
ml and 8 mg/ml, respectively).
Although all O1 isolates were sensitive to
chloramphenicol, there was only a twofold
difference in MIC90 to chloramphenicol between
O1 and O139 isolates. MIC90s of ofloxacin for
O139 were nearly 10 times higher than those for
O1 strains.
The novel appearance of O139 resistant to
ofloxacin with MICs of 16 mg/ml from Guangdong
Province, China, was of special concern.
Preliminary results using pulsed-field gel
electrophoresis analysis of chromosomal DNA
showed that these ofloxacin-resistant O139
strains had identical fingerprint patterns and
probably belonged to the clone that had caused
severe diarrheal disease in the region. Two
previous surveys of V. cholerae antibiotic
susceptibilities had not described any ofloxacin-
resistant O139 strains (15,16). The potential for
rapid spread of these strains threatens cholera
prevention and control efforts that may still rely
on chemotherapy.
Different antimicrobial resistance patterns
of V. cholerae O1 and O139 were noted. Among
the resistant O1 isolates, four were local, one was
from other provinces of China, and one was from
Thailand. All the resistant O139 isolates were
imported from Guangdong Province, China.
Antibiotic resistance was found in strains from
local isolates and from neighboring countries.
The unique patterns of antimicrobial resistance
for the O1 and O139 isolates suggest different
mechanisms of resistance. As quinolones are used
heavily in this region to treat cholera and other
enteric diseases, selective pressure could encour-
age emergence of ofloxacin resistance. Prudent
use of antibiotics should be exercised during
antimicrobial therapy and prophylaxis for cholera
and other enteric diseases to decrease the
selection of more resistant clones in our locality.
Kai Man Kam, Kit Yee Luey, Tze Leung
Cheung, Kwan Yee Ho, Kwok Hang Mak, and
Paul Thian Aun Saw
Department of Health, Hong Kong SAR Government
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Plant Pathology and Public Health
The day will come when the sign of the plant
pathologist will stand forth in the street alongside
that of the physician and surgeon. . . . For what will
it profit us if all the ills and diseases of the human
race be banished and we then face starvation
because of diseases and pests in our food (1).
To the Editor: Every year plant diseases affect
human society, resulting in inadequate nutrition
and economic loss. The potato famine in the mid-
1800s is the best-known example of a fungal
plant pathogens effect on history (2-4);
Phytopthora infestans has recently reemerged in
the Americas (5). Among the silent problems that
have enormous effects on human society each
year are crop infections by geminiviruses and
tomato spotted wilt virus (6). These plant viruses
are transmitted by whiteflies, leafhoppers, or
thrips to hundreds of species of plants. They
cause diseases of crops and ornamental plants
around the world.
More obvious problems include ergotism,
caused by the alkaloids produced by the fungus
Claviceps purpurea. Ergotism was associated
with the growth of rye, particularly in cool
climates that cannot support wheat, and was
implicated in the aberrant human behavior
responsible at least in part for the Salem witch
trials and St. Anthonys fire (2,7). In the last 5
years, a new plant disease, sorghum ergot
(Claviceps africana), has spread north from
Brazil into the United States. This fungus also
causes disease in Australia, a sudden change
from its known occurrence in Africa (8).
Sorghum is the fifth most important cereal crop
in the world, with approximately 45 million
hectares under cultivation for food, beverages,
feed, and fodder (8). Ergot alkaloid toxicity has
not yet been demonstrated, but potential
nutritional and economic losses could have
substantial impact on public health.
With our increased awareness of the fragility
of the environment, including the quality of our
drinking water, opportunities may exist for
physicians to interact with plant pathologists.
Concern is growing about the use of Burkholderia
cepacia, a bacterial phytopathogen, for the
biologic control of seedling diseases (9). Although
B. cepacia is effective for the biologic control of
fungal diseases in the agricultural environment
(10), this bacterium could contaminate the public
water supply and subsequently influence the
health of the immunosuppressed or persons with
cystic fibrosis (9-11). This risk exemplifies the
need to integrate plant health measures with
human and veterinary health guidelines.
Plant pathology and public health also
intersect with post-harvest fungal infections of
seed and grain, particularly Aspergillus flavus and
Fusarium moniliforme (2), which produce aflatox-
in and fumonisin, respectively. During the past 2
drought years in Texas, aflatoxin in contaminat-
ed corn and peanuts has become a public health
problem. In 1998, more than 50 pet dogs died of
aflatoxicosis, perhaps by eating aflatoxin B1-
contaminated corn used in dog food (12).
Although the veterinary and medical
communities are well aware of the risks
associated with plant pathogens when they enter
the animal or human food supply, more routine
interactions with plant pathologists could
benefit public health. For example, plant
pathologists can often predict impending plant
disease outbreaks. This information can be used
by epidemiologists to sound a warning about
impending food shortages or poor food quality,
particularly in developing countries. Plant
pathologists are also developing new types of
resistance in host plants and alternative
strategies for managing plant diseases. These
measures should improve food quality and
reduce the negative public health impact
associated with plant diseases.
Karen-Beth G. Scholthof
Texas A&M University, College Station, Texas, USA
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